Literature DB >> 9757070

Methamphetamine-induced increase in striatal NF-kappaB DNA-binding activity is attenuated in superoxide dismutase transgenic mice.

M Asanuma1, J L Cadet.   

Abstract

Methamphetamine injection (x4 with 2-h interval) caused dose-dependent activation of striatal NF-kappaB activity. Striatal NF-kappaB binding increased significantly at 1-3 h after the last injection of methamphetamine (10 mg/kg, i.p. x4). This induction of striatal NF-kappaB activity was significantly attenuated in Cu, Zn-superoxide dismutase transgenic mice in a gene dosage-dependent fashion. The present results suggest that reactive oxygen species generated by methamphetamine injections can activate striatal NF-kappaB DNA-binding during this drug-induced toxic process. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9757070     DOI: 10.1016/s0169-328x(98)00188-0

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  20 in total

1.  Unique genetic factors influence sensitivity to the rewarding and aversive effects of methamphetamine versus cocaine.

Authors:  Noah R Gubner; Cheryl Reed; Carrie S McKinnon; Tamara J Phillips
Journal:  Behav Brain Res       Date:  2013-08-28       Impact factor: 3.332

Review 2.  Review. Transcriptional mechanisms of addiction: role of DeltaFosB.

Authors:  Eric J Nestler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

3.  Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells.

Authors:  Emily S Wires; David Alvarez; Curtis Dobrowolski; Yun Wang; Marisela Morales; Jonathan Karn; Brandon K Harvey
Journal:  J Neurovirol       Date:  2012-05-22       Impact factor: 2.643

4.  Genetically correlated effects of selective breeding for high and low methamphetamine consumption.

Authors:  J M Wheeler; C Reed; S Burkhart-Kasch; N Li; C L Cunningham; A Janowsky; F H Franken; K M Wiren; J G Hashimoto; A C Scibelli; T J Phillips
Journal:  Genes Brain Behav       Date:  2009-07-21       Impact factor: 3.449

5.  Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity.

Authors:  X Deng; B Ladenheim; L I Tsao; J L Cadet
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

Review 6.  Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4.

Authors:  Ryan Bachtell; Mark R Hutchinson; Xiaohui Wang; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  CNS Neurol Disord Drug Targets       Date:  2015       Impact factor: 4.388

7.  Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation.

Authors:  Govinder Flora; Yong Woo Lee; Avindra Nath; William Maragos; Bernhard Hennig; Michal Toborek
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

8.  Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward.

Authors:  Scott J Russo; Matthew B Wilkinson; Michelle S Mazei-Robison; David M Dietz; Ian Maze; Vaishnav Krishnan; William Renthal; Ami Graham; Shari G Birnbaum; Thomas A Green; Bruce Robison; Alan Lesselyong; Linda I Perrotti; Carlos A Bolaños; Arvind Kumar; Michael S Clark; John F Neumaier; Rachael L Neve; Asha L Bhakar; Philip A Barker; Eric J Nestler
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

Review 9.  Molecular mechanisms of psychostimulant-induced structural plasticity.

Authors:  D M Dietz; K C Dietz; E J Nestler; S J Russo
Journal:  Pharmacopsychiatry       Date:  2009-05-11       Impact factor: 5.788

10.  Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen.

Authors:  Takeshi Tsuji; Masato Asanuma; Ikuko Miyazaki; Ko Miyoshi; Norio Ogawa
Journal:  Neurochem Res       Date:  2008-10-23       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.